<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03811964</url>
  </required_header>
  <id_info>
    <org_study_id>6791</org_study_id>
    <nct_id>NCT03811964</nct_id>
  </id_info>
  <brief_title>Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies</brief_title>
  <official_title>Study of the Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The light has visual and non-visual effects on organism and can act on the behavior, the&#xD;
      mood, the cognition and the sleep. These effects are mediated by &quot;classical&quot; retina&#xD;
      photoreceptors which allow vision (rods, cones) but also melanopsin cells. The non-visual&#xD;
      effects of light seems to be altered in many neurological, psychiatric or ophtalmological&#xD;
      conditions but their exact role in the pathogenesis remains poorly understand. The purpose of&#xD;
      the study is to increase our knowledge of the non-visual effects of light and establish new&#xD;
      therapeutic applications&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 22, 2020</start_date>
  <completion_date type="Anticipated">February 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PIPR : Post-Illumination Pupil Response</measure>
    <time_frame>1 day</time_frame>
    <description>1 measurement per subject is performed after exposure to monochromatic light exposure</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">726</enrollment>
  <condition>Sleep Disorders</condition>
  <condition>Neurological Pathologies</condition>
  <condition>Psychiatric Pathologies</condition>
  <condition>Ophthalmological Pathologies</condition>
  <arm_group>
    <arm_group_label>primary sleep-wake disorder</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects with primary sleep-wake disorder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>neurological pathology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects presenting a neurological pathology with disorder of the controls of the wake and the sleep</description>
  </arm_group>
  <arm_group>
    <arm_group_label>psychiatric pathology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subject presenting a psychiatric pathology with disorder of the controls of the wake and the sleep</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ophthalmological pathology</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subject presenting an ophthalmological pathology with possible alteration of the photoreception and / or phototransduction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>photosensitivity</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>subjects with photosensitivity with regulation disorder of sleep and wake</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>healthy subject</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Specific light exposures</intervention_name>
    <description>Specific light exposures using light in a wide range of intensities or different light/dark regimens</description>
    <arm_group_label>group control</arm_group_label>
    <arm_group_label>neurological pathology</arm_group_label>
    <arm_group_label>ophthalmological pathology</arm_group_label>
    <arm_group_label>photosensitivity</arm_group_label>
    <arm_group_label>primary sleep-wake disorder</arm_group_label>
    <arm_group_label>psychiatric pathology</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Man or woman&#xD;
&#xD;
          -  Aged 18 years or older&#xD;
&#xD;
          -  Subject having signed a free and informed consent&#xD;
&#xD;
          -  Subject affiliated to a social protection scheme Arm 1 :Subjects with primary&#xD;
             sleep-wake disorder Arm 2 : subjects presenting a neurological pathology with disorder&#xD;
             of the controls of the wake and the sleep Arm 3 : subject presenting a psychiatric&#xD;
             pathology pathology with disorder of the controls of the wake and the sleep Arm 4 :&#xD;
             subject presenting an ophthalmological pathology with possible alteration of the&#xD;
             photoreception and / or phototransduction Arm 5 : subjects with photosensitivity with&#xD;
             regulation disorder of sleep and wake Arm 6 : healthy subject&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Age-Related Macular Degeneration (AMD) and all maculopathies (retinopathies pigmentosa,&#xD;
        macular involvement of diabetes)&#xD;
&#xD;
          -  Cataract with significant vision loss &lt;5/10&#xD;
&#xD;
          -  Chorioretinal neovascularization&#xD;
&#xD;
          -  Subject in exclusion period determined by previous or current study&#xD;
&#xD;
          -  Impossibility to give the subject information enlightened (subject in emergency&#xD;
             situation, difficulties of understanding the subject, ...)&#xD;
&#xD;
          -  Subject under the protection of justice&#xD;
&#xD;
          -  Subject under guardianship or curatorship&#xD;
&#xD;
          -  Pregnancy / Breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bourgin Patrice, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bourgin Patrice, MD</last_name>
    <phone>03 88 11 64 30</phone>
    <phone_ext>0033</phone_ext>
    <email>pbourgin@unistra.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital, Strasbourg, France</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bourgin Patrice, MD</last_name>
      <phone>03 88 11 64 30</phone>
      <phone_ext>0033</phone_ext>
      <email>pbourgin@unistra.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 9, 2019</study_first_submitted>
  <study_first_submitted_qc>January 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2019</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Wake Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

